In primary breast cancer, mutations of the p53 tumor suppressor gene lead to loss of growth-suppressive properties and poor outcome. Recently, a p53-related gene, termed p73, has been cloned and its gene product possesses a function similar to p53. p73 has been mapped at chromosome 1p36.3, a region
Mutational Analysis of Estrogen Receptor-Beta Gene in Human Breast Cancers
β Scribed by Seiichi Hasegawa; Yasuo Miyoshi; Noriko Ikeda; Chiyomi Egawa; Yasuhiro Tamaki; Morito Monden; Shinzaburo Noguchi
- Book ID
- 110415191
- Publisher
- Springer US
- Year
- 2003
- Tongue
- English
- Weight
- 39 KB
- Volume
- 78
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
It is fairly well accepted that the presence of estrogen receptor (ER) identifies those breast cancer patients with a lower risk of relapse and better overall survival [Clark and McGuire, 19881, and the measurement of ER has become a standard assay in the clinical management of breast cancer. Recept
## Abstract Exposure to exogenous (oral contraceptives, postmenopausal hormone therapy) and endogenous (number of ovulatory cycles, adiposity) steroid hormones is associated with breast cancer risk. Breast cancer risk associated with these exposures could hypothetically be modified by genes in the